APVO
Aptevo Therapeutics·NASDAQ
--
--(--)
--
--(--)
APVO fundamentals
Aptevo Therapeutics (APVO) released its earnings on Aug 11, 2025: revenue was 0 (YoY --), met estimates; EPS was -151.2 (YoY +99.32%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-151.2
+99.32%
Report date
Aug 11, 2025
EPS
Actual | -1793404.8 | -1230768 | -1260072 | -1060804.8 | -1019779.2 | -1043222.4 | -849816 | -761904 | -931867.2 | 3252942.095 | -898116.611 | -621244.8 | 152380.8 | -720878.4 | -293040 | -178887.6 | -132534 | -22244.4 | -6393.6 | -3218.4 | -1580.4 | -151.2 | ||||||
Forecast | -820512 | -1240536 | -1201464 | -908424 | -980707.2 | -1172160 | -838094.4 | -758973.6 | -673992 | -779486.4 | -955310.4 | -896702.4 | -694504.8 | -656409.6 | -375091.2 | -263736 | -143456.4 | -25707.6 | -7592.4 | -2790 | -1515.6 | -1497.6 | ||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -118.57% | +0.79% | -4.88% | -16.77% | -3.98% | +11.00% | -1.40% | -0.39% | -38.26% | +517.32% | +5.99% | +30.72% | +121.94% | -9.82% | +21.88% | +32.17% | +7.61% | +13.47% | +15.79% | -15.35% | -4.28% | +89.90% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | 0 | 473.00K | 1.50M | 2.37M | 2.42M | 3.11M | 3.10M | 3.66M | 3.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | 0 |
Forecast | -- | -- | -- | -- | -- | -- | 4.50M | 290.00K | 563.67K | 2.22M | 2.42M | 1.35M | 3.10M | 3.40M | 3.75M | 3.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | +63.10% | +166.11% | +7.08% | 0.00% | +130.37% | 0.00% | +7.71% | -16.96% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Aptevo Therapeutics’s earnings call?Did Aptevo Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Aptevo Therapeutics year over year?What is the market's earnings forecast for Aptevo Therapeutics next quarter?What is Aptevo Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Aptevo Therapeutics's earnings call?What does Aptevo Therapeutics do and what are its main business segments?What is Aptevo Therapeutics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
